Search Results - "Fehmann, H C"

Refine Results
  1. 1

    Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls by Fehmann, H-C, Heyn, J

    Published in Hormone and metabolic research (01-11-2002)
    “…Resistin is a recently discovered hormone that is exclusively expressed in adipose tissue. Its expression in rodents was reported to be elevated or suppressed…”
    Get more information
    Journal Article
  2. 2

    Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells by Goke, R, Fehmann, H.C, Linn, T, Schmidt, H, Krause, M, Eng, J, Goke, B

    Published in The Journal of biological chemistry (15-09-1993)
    “…Exendin-4 purified from Heloderma suspectum venom shows structural relationship to the important incretin hormone glucagon-like peptide 1-(7-36)- amide…”
    Get full text
    Journal Article
  3. 3

    Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells by Fehmann, H C, Habener, J F

    Published in Endocrinology (Philadelphia) (01-01-1992)
    “…Glucagon-like peptide-I(7-37) [GLP-I(7-37)] is an intestinal peptide hormone that is released in response to oral nutrients and that potently augments…”
    Get more information
    Journal Article
  4. 4

    Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients by Herrmann, C, Göke, R, Richter, G, Fehmann, H C, Arnold, R, Göke, B

    Published in Digestion (1995)
    “…The nutrient-dependent glucagon-like peptide-1 (7-36) amide (GLP-1) release was studied in comparison to the glucose-dependent insulin-releasing polypeptide…”
    Get more information
    Journal Article
  5. 5

    mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours by Wulbrand, U, Remmert, G, Zöfel, P, Wied, M, Arnold, R, Fehmann, H C

    Published in European journal of clinical investigation (01-08-2000)
    “…Background Insulin‐like growth factors (IGF) and their corresponding receptors and binding proteins are important in carcinogenesis for several tumours, but…”
    Get full text
    Journal Article
  6. 6

    Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide by Kolligs, F., Fehmann, H. C., Goke, R., Goke, B.

    Published in Diabetes (New York, N.Y.) (01-01-1995)
    “…Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. F Kolligs , H C Fehmann , R Göke and B Göke…”
    Get full text
    Journal Article
  7. 7

    Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours by WULBRAND, U, WIED, M, ZÖFEL, P, GÖKE, B, ARNOLD, R, FEHMANN, H.-C

    Published in European journal of clinical investigation (01-12-1998)
    “…Background Human gastroenteropancreatic neuroendocrine tumours are functionally and biologically heterogeneous, but their exact growth factor receptor…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Leptin inhibition of insulin secretion from isolated human islets by FEHMANN, H. C, BERGHÖFER, P, BRANDHORST, D, BRANDHORST, H, HERING, B, BRETZEL, R. G, GÖKE, B

    Published in Acta diabetologica (01-12-1997)
    “…Leptin is a hormone produced and secreted from the adipose tissue. Its physiological actions include the regulation of satiety, food intake and energy balance…”
    Get full text
    Journal Article
  12. 12

    Synergistic stimulatory effect of glucagon-like peptide-1 (7–36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas by Fehmann, H.-C., Göke, B., Göke, R., Trautmann, M.E., Arnold, R.

    Published in FEBS letters (31-07-1989)
    “…The interaction of glucagon-like peptide-1 (7–36)amide (GLP-1) and glucose-dependent insulin-releasing polypeptide (GIP) on insulin release from the perfused…”
    Get full text
    Journal Article
  13. 13

    Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction by Fehmann, H C, Bode, H P, Ebert, T, Karl, A, Göke, B

    Published in Hormone and metabolic research (01-11-1997)
    “…The incretin effect is reduced in NIDDM, although a corresponding attenuation of incretin hormone secretion does not occur. We characterized the direct…”
    Get more information
    Journal Article
  14. 14

    Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39) by Fehmann, H C, Jiang, J, Schweinfurth, J, Wheeler, M B, Boyd, 3rd, A E, Göke, B

    Published in Peptides (New York, N.Y. : 1980) (1994)
    “…Glucagon-like peptide-I (GLP-I) is a potent insulinotropic peptide that mediates its actions at pancreatic B-cells via specific receptors. In the present study…”
    Get more information
    Journal Article
  15. 15

    Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma by Volz, Anja, Göke, Rüdiger, Lankat-Buttgereit, Brigitte, Fehmann, Hans-C., Bode, Hans P., Göke, Burkhard

    Published in FEBS letters (02-10-1995)
    “…Glucose-dependent insulinotropic polypeptide (GIP) plays an important role in the regulation of postprandial insulin secretion and proinsulin gene expression…”
    Get full text
    Journal Article
  16. 16

    Cosecretion of amylin and insulin from isolated rat pancreas by Fehmann, H.C., Weber, V., Göke, R., Göke, B., Arnold, R.

    Published in FEBS letters (26-03-1990)
    “…Amylin, a 37 amino acid C-terminal amidated peptide is an integral part of secretory granules of pancreatic β-cells. Utilizing a specific radioimmunoassay…”
    Get full text
    Journal Article
  17. 17

    Treatment of endocrine gastroenteropancreatic tumors with somatostatin analogues by Fehmann, H C, Wulbrand, U, Arnold, R

    Published in Recent results in cancer research (2000)
    “…Somatostatin is a hormone that regulates the function of several exocrine and endocrine glands. The peptide mediates its actions via five different receptors…”
    Get more information
    Journal Article
  18. 18

    No apparent benefit of liquid formula diet in NIDDM by Printz, H, Recke, B, Fehmann, H C, Göke, B

    “…We have studied the impact of liquid diets formulated for complete or supplemental enteral nutrition of type II, non insulin-dependent (NIDDM) diabetics on…”
    Get more information
    Journal Article
  19. 19

    Functional characterization of somatostatin receptors expressed on hamster glucagonoma cells by Fehmann, H C, Strowski, M, Göke, B

    Published in The American journal of physiology (01-01-1995)
    “…We characterized somatostatin receptors expressed in hamster glucagonoma INR1G9 cells and the effects of somatostatin on glucagon secretion, proglucagon gene…”
    Get full text
    Journal Article
  20. 20

    Leptin: A Potent Inhibitor of Insulin Secretion by Fehmann, Hans-Christoph, Peiser, Christian, Bode, Hans-Peter, Stamm, Matthias, Staats, Petra, Hedetoft, Christoffer, Lang, Rudolf Ernst, Göke, Burkhard

    Published in Peptides (New York, N.Y. : 1980) (1997)
    “…Fehmann, H.-C., C. Peiser, H.-P. Bode, M. Stamm, P. Staats, C. Hedetoft, R. E. Lang and B. GÖKe. Leptin: A potent inhibitor of insulin secretion. Peptides…”
    Get full text
    Journal Article